The numbers of people who are suffering from rampant coronavirus are continuing to skyrocket and prompting everyone to be extra cautious when outside. A new report reveals that a cure may be found in the form of repurposed HIV/AIDS drugs.
Express reports that the virus, having originated in Wuhan, China, has now affected thousands of people in the country and is spreading to the rest of the world. The number of fatalities recorded has also skyrocketed as well, with 132 people dying from this new strain of the coronavirus. This has health officials all over the world working harder to find or develop a cure, even including the existing drugs in the market. Among those options came in the form of two drugs known as lopinavir and ritonavir, and both of which are used to treat patients suffering from HIV/AIDS.
According to Warsaw Medical University Professor Dr. Ernest Kuchar, the two drugs would become a breakthrough in the epidemic, which has spread to other countries including the United States, Singapore, South Korea, Japan, Thailand, Hong Kong, Taiwan, Australia, Nepal, Canada, Vietnam, France, Malaysia, the UAE, Cambodia, Macau, and Germany. Neighboring countries with China, such as Mongolia, have been reported to close border crossings to prevent the spread of the virus. Although the two drugs may offer some hope to the patients who are infected, Dr. Kuchar said that clinical trials with patients still need to be done in order to test the effectiveness.
The local authorities in Wuhan have also placed the city on total lockdown, preventing anyone from entering or leaving so as not to spread the virus even further.
All the same, scientists all over are working harder to try and develop a vaccine to finally put an end to the pandemic once and for all. The downside to this is that it may take a year to develop a vaccine for this strain of coronavirus. Five teams of scientists under Johnson & Johnson have already begun trying to develop a drug for the pandemic for a few weeks now and have expressed confidence that they can be able to create a cure. Paul Stoffels, the Chief Scientific Officer said, “I’m very worried that this could become a global pandemic. That’s why we started working on this vaccine two weeks ago, we have to be prepared that this is going to become a global crisis.”
But he warned that a vaccine for the coronavirus might take up to a year to develop. Still, he expressed hope that there would be some success in a few weeks’ time.


GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
3 clinical-grade skincare creams you really shouldn’t buy online
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 



